Recent News

• 05.01.2025 - Blueprint Medicines 1Q 2025 Earnings Conference Call
• 05.01.2025 - Blueprint Medicines 1Q 2025 Earnings Conference Call
• 04.25.2025 - Blueprint Medicines to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
• 04.25.2025 - Blueprint Medicines to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
• 04.07.2025 - 24th Annual Needham Virtual Healthcare Conference
• 04.07.2025 - 24th Annual Needham Virtual Healthcare Conference
• 03.31.2025 - Blueprint Medicines to Present at 24th Annual Needham Virtual Healthcare Conference
• 03.31.2025 - Blueprint Medicines to Present at 24th Annual Needham Virtual Healthcare Conference
• 03.27.2025 - H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference (Skin Diseases, Conditions and Disorders)
• 03.27.2025 - H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference (Skin Diseases, Conditions and Disorders)

Recent Filings

• 04.24.2025 - DEF 14A Other definitive proxy statements
• 04.24.2025 - ARS Annual Report to Security Holders
• 04.24.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.23.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 04.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.01.2025 - 144 Report of proposed sale of securities
• 03.26.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.24.2025 - 144 Report of proposed sale of securities